Results 131 to 140 of about 27,778 (225)

Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521]. [PDF]

Int J Infect Dis, 2021
Pandit A, Bhalani N, Bhushan BLS, Koradia P, Gargiya S, Bhomia V, Kansagra K.   +6 more
europepmc   +1 more source

Intralesional Interferon Alfa-2b Versus Cryotherapy for Common Warts on the Hands and Feet: A Randomized, Open-Label, Controlled Trial. [PDF]

J Cosmet Dermatol
Jin Y, Shen X.
europepmc   +1 more source

Recombinant Interferon Alfa [PDF]

, 2020
openaire   +1 more source

Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance). [PDF]

Cancer Immunol Res
Liu A, Johnson C, Niedzwiecki D, Relation T, Yarlagadda SV, Gajewski TF, Carson WE.   +6 more
europepmc   +1 more source

Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b. [PDF]

Rom J Ophthalmol, 2020
Rocha-de-Lossada C, Alba-Linero C, Borroni D, Rachwani-Anil R, Zamorano-Martín F, Rodríguez-Calvo-de-Mora M.   +5 more
europepmc   +1 more source

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma. [PDF]

Clin Cancer Res, 2021
Najjar YG, McCurry D, Lin H, Lin Y, Zang Y, Davar D, Karunamurthy A, Drabick JJ, Neves RI, Butterfield LH, Ernstoff MS, Puzanov I, Skitzki JJ, Bordeaux J, Summit IB, Bender JO, Kim JY, Chen B, Sarikonda G, Pahuja A, Tsau J, Alfonso Z, Laing C, Pingpank JF, Holtzman MP, Sander C, Rose A, Zarour HM, Kirkwood JM, Tarhini AA.   +29 more
europepmc   +1 more source

Efficacy and safety of posterior subtenon interferon alfa-2B injection in recurrent inflammatory macular edema. [PDF]

Indian J Ophthalmol
Kawali A, Mishra SB, Mahendradas P, Shetty R.   +3 more
europepmc   +1 more source

Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa. [PDF]

Blood Adv
Kalmer M, Grasshoff M, Maié T, Pannen K, Toledo MAS, Vieri M, Olschok K, Lemanzyk R, Lazarevic J, Junge B, Baumeister J, Galauner A, Chapal Ilani N, Bar D, Colin E, Cheng M, Schifflers J, Kricheldorf K, Schemionek M, Brümmendorf TH, Weiskirchen R, Shlush L, Zenke M, Chatain N, Costa IG, Koschmieder S.   +25 more
europepmc   +1 more source

Incidence and predictors of HBsAg loss following addition of pegylated interferon Alfa-2b in chronic hepatitis B patients suppressed by nucleos(t)ide analogues: a multicenter, prospective, cohort study. [PDF]

Virol J
Zhao J, Bian D, Xie D, Lv J, Lin L, Chen X, Zhang L, Feng B, Xu X, Lu F, Zheng S.   +10 more
europepmc   +1 more source